# Bimergen Energy Corp: financial statements, quarterly

BESS · NYSE · CIK 1066764 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bess.md) · [Financials](/companies/bess/financials.md) · [Filings](/companies/bess/filings.md) · [Insiders](/companies/bess/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bess/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | [0.3](/filings/0001493152-24-019929.md) | [0.0 d](/filings/0001493152-24-041621.md) | [0.0 d](/filings/0001493152-24-045374.md) | not reported | not reported | not reported | not reported | not reported | not reported | [7,903](/filings/0001493152-26-038439.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [3,090](/filings/0001493152-26-038439.md) |
| Gross profit | $k | not reported | not reported | [0.3](/filings/0001493152-24-019929.md) | [0.0 d](/filings/0001493152-24-041621.md) | [0.0 d](/filings/0001493152-24-045374.md) | not reported | not reported | not reported | not reported | not reported | not reported | [4,813](/filings/0001493152-26-038439.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(135)](/filings/0001493152-24-045374.md) | [(331) d](/filings/0001641172-25-013018.md) | [(314)](/filings/0001641172-25-014338.md) | [(823)](/filings/0001641172-25-024074.md) | [(812)](/filings/0001493152-25-022560.md) | [(810) d](/filings/0001493152-26-014356.md) | [(857)](/filings/0001493152-26-023798.md) | [(816)](/filings/0001493152-26-038439.md) | [(1,780)](/filings/0001493152-25-022560.md) | [(1,476) d](/filings/0001493152-26-014356.md) | [(3,765)](/filings/0001493152-26-023798.md) | [1,573](/filings/0001493152-26-038439.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0001493152-26-023798.md) | [5.3](/filings/0001493152-26-038439.md) | [15.2](/filings/0001493152-25-022560.md) | [23.4 d](/filings/0001493152-26-014356.md) | [13.1](/filings/0001493152-26-023798.md) | [4.5](/filings/0001493152-26-038439.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(135)](/filings/0001493152-24-045374.md) | [(330) d](/filings/0001641172-25-013018.md) | [(314)](/filings/0001493152-25-022560.md) | [(823)](/filings/0001493152-25-022560.md) | [(812)](/filings/0001493152-25-022560.md) | [(810) d](/filings/0001493152-26-014356.md) | [(858)](/filings/0001493152-26-038439.md) | [(821)](/filings/0001493152-26-038439.md) | [(1,795)](/filings/0001493152-25-022560.md) | [(1,499) d](/filings/0001493152-26-014356.md) | [(3,752)](/filings/0001493152-26-038439.md) | [1,628](/filings/0001493152-26-038439.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-045374.md) | not reported | [(0.09)](/filings/0001641172-25-014338.md) | [(0.18)](/filings/0001641172-25-024074.md) | [(0.16)](/filings/0001493152-25-022560.md) | not reported | [(0.17)](/filings/0001493152-26-023798.md) | [(0.16)](/filings/0001493152-26-038439.md) | [(0.47)](/filings/0001493152-25-022560.md) | not reported | [(0.71)](/filings/0001493152-26-023798.md) | [0.22](/filings/0001493152-26-038439.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-045374.md) | not reported | [(0.09)](/filings/0001641172-25-014338.md) | [(0.18)](/filings/0001641172-25-024074.md) | [(0.16)](/filings/0001493152-25-022560.md) | not reported | [(0.17)](/filings/0001493152-26-023798.md) | [(0.16)](/filings/0001493152-26-038439.md) | [(0.47)](/filings/0001493152-25-022560.md) | not reported | [(0.71)](/filings/0001493152-26-023798.md) | [0.22](/filings/0001493152-26-038439.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-23-041190.md) | [0.2](/filings/0001641172-25-013018.md) | [0.2](/filings/0001493152-24-019929.md) | [1.1](/filings/0001493152-24-041621.md) | [0.3](/filings/0001493152-24-045374.md) | [0.2](/filings/0001493152-26-014356.md) | [0.1](/filings/0001641172-25-014338.md) | [0.0](/filings/0001641172-25-024074.md) | [0.1](/filings/0001493152-25-022560.md) | [0.4](/filings/0001493152-26-038439.md) | [8.9](/filings/0001493152-26-023798.md) | [9.4](/filings/0001493152-26-038439.md) |
| Current assets | $m | [0.1](/filings/0001493152-23-041190.md) | [0.2](/filings/0001641172-25-013018.md) | [0.2](/filings/0001493152-24-019929.md) | [1.1](/filings/0001493152-24-041621.md) | [0.7](/filings/0001493152-24-045374.md) | [1.0](/filings/0001493152-26-014356.md) | [1.0](/filings/0001641172-25-014338.md) | [0.9](/filings/0001641172-25-024074.md) | [1.0](/filings/0001493152-25-022560.md) | [3.3](/filings/0001493152-26-038439.md) | [11.4](/filings/0001493152-26-023798.md) | [14.6](/filings/0001493152-26-038439.md) |
| Total assets | $m | [0.1](/filings/0001493152-23-041190.md) | [0.2](/filings/0001641172-25-013018.md) | [0.2](/filings/0001493152-24-019929.md) | [23.4](/filings/0001493152-24-041621.md) | [22.9](/filings/0001493152-24-045374.md) | [23.3](/filings/0001493152-26-014356.md) | [23.2](/filings/0001641172-25-014338.md) | [23.2](/filings/0001641172-25-024074.md) | [23.2](/filings/0001493152-25-022560.md) | [27.2](/filings/0001493152-26-038439.md) | [35.3](/filings/0001493152-26-023798.md) | [38.4](/filings/0001493152-26-038439.md) |
| Current liabilities | $m | [0.0](/filings/0001493152-23-041190.md) | [0.0](/filings/0001641172-25-013018.md) | [0.1](/filings/0001493152-24-019929.md) | [1.1](/filings/0001493152-24-041621.md) | [1.2](/filings/0001493152-24-045374.md) | [1.8](/filings/0001493152-26-014356.md) | [2.2](/filings/0001641172-25-014338.md) | [2.6](/filings/0001641172-25-024074.md) | [3.3](/filings/0001493152-25-022560.md) | [7.8](/filings/0001493152-26-038439.md) | [5.2](/filings/0001493152-26-023798.md) | [5.0](/filings/0001493152-26-038439.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001493152-26-038439.md) | not reported | not reported |
| Shareholders' equity | $m | [0.1](/filings/0001493152-24-045374.md) | [0.1](/filings/0001493152-26-014356.md) | [0.2](/filings/0001493152-25-022560.md) | [22.2](/filings/0001493152-25-022560.md) | [21.8](/filings/0001493152-25-022560.md) | [21.5](/filings/0001493152-26-038439.md) | [21.1](/filings/0001493152-26-038439.md) | [20.5](/filings/0001493152-26-038439.md) | [19.9](/filings/0001493152-25-022560.md) | [19.4](/filings/0001493152-26-038439.md) | [30.2](/filings/0001493152-26-038439.md) | [33.1](/filings/0001493152-26-038439.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(105) d](/filings/0001493152-24-045374.md) | [(80.8) d](/filings/0001641172-25-013018.md) | [(166)](/filings/0001641172-25-014338.md) | [766 d](/filings/0001641172-25-024074.md) | [(682) d](/filings/0001493152-25-022560.md) | [(267) d](/filings/0001493152-26-014356.md) | [(142)](/filings/0001493152-26-023798.md) | [(317) d](/filings/0001493152-26-038439.md) | [(327) d](/filings/0001493152-25-022560.md) | [1,665 d](/filings/0001493152-26-014356.md) | [(2,921)](/filings/0001493152-26-023798.md) | [469 d](/filings/0001493152-26-038439.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [535](/filings/0001493152-23-041190.md) | [494](/filings/0001493152-24-019929.md) | [467](/filings/0001493152-24-041621.md) | [476](/filings/0001493152-24-045374.md) | [3.5](/filings/0001641172-25-014338.md) | [4.7](/filings/0001641172-25-024074.md) | [5.1](/filings/0001493152-25-022560.md) | [5.1](/filings/0001493152-26-023798.md) | [5.1](/filings/0001493152-26-038439.md) | [3.9](/filings/0001493152-25-022560.md) | [5.3](/filings/0001493152-26-023798.md) | [7.4](/filings/0001493152-26-038439.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,097,573 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038439.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.